Gilead Sciences, Inc
XMUN:GIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences, Inc
XMUN:GIS
|
US |
|
Bank of Montreal
TSX:BMO
|
CA |
|
S
|
Swiss Re AG
DUS:SR9
|
CH |
|
B
|
Bollore SE
XMUN:BOP
|
FR |
|
Christian Dior SE
PAR:CDI
|
FR |
|
SITC International Holdings Co Ltd
F:7S8
|
HK |
|
L
|
LY Corp
SWB:YOJ
|
JP |
|
K
|
Kering SA
XHAM:PPX
|
FR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GIS's stock price target?
Price Target
146.64
EUR
According to Wall Street analysts, the average 1-year price target for 
GIS is 146.64 EUR with a low forecast of 108.24 EUR and a high forecast of 164.67 EUR.
What is the Revenue forecast for Gilead Sciences, Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 4%.
What is the Gross Profit forecast for Gilead Sciences, Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Gilead Sciences, Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 8%.
What is the Pre-Tax Income forecast for Gilead Sciences, Inc?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for Gilead Sciences, Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 9%.